Asta Medica GmbH
This article was originally published in The Tan Sheet
Executive Summary
Petitions FDA on Sept. 3 to allow the filing of an ANDA for an effervescent OTC dosage form of loperamide HCI 1 mg. Asta Medica said its proposed product is identical to McNeil's Imodium A-D in active ingredient, route of administration, strength and safety and effectiveness.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning